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 Loss-of-function mutations in the gene encoding for the LKB1 
tumor suppressor protein kinase were discovered 10 yr ago 
to cause the rare inherited Peutz-Jeghers cancer syndrome, in 
which patients are predisposed to develop benign as well as 
malignant tumors in multiple tissues ( Hemminki et al., 1998 ). 
This observation gave birth to a new industry of research aimed 
at understanding how LKB1 exerts its cancer-suppressive ef-
fects. Much is still not understood. What is becoming clear is 
that LKB1 is mutated in a signifi cant number of sporadic can-
cers, most frequently in adenocarcinomas of the lung ( Sanchez-
Cespedes, 2007 ). At the molecular level, LKB1 is activated by 
forming a heterotrimeric complex with the STRAD pseudo-
kinase and the armadillo repeat adaptor protein MO25 ( Alessi 
et al., 2006 ). Most evidence points to LKB1 exerting its physio-
logical effects by phosphorylating a group of 14 protein kinases 
that belong to the AMP-activated protein kinase (APMK) sub-
family ( Lizcano et al., 2004 ). The most studied members are 
AMPK  1 and AMPK  2. These are normally referred to as AMPK 
and are activated by LKB1 after rises in 5  -AMP levels in energy-
stressed cells. They phosphorylate a plethora of proteins to 
restore energy levels and stimulate the transport of glucose and 
other nutrients into cells ( Hardie and Sakamoto, 2006 ). AMPK 
activation also suppresses nonessential energy-consuming pro-
cesses such as protein synthesis and growth. The 12 other LKB1-
activated kinases are collectively termed AMPK-related kinases. 
A question preoccupying many researchers is how signal 
transduction pathways control metabolic processes and 
energy production. A study by Jang et al. ( Jang, C., 
G. Lee, and J. Chung. 2008 .  J. Cell Biol. 183: 11–17 ) pro-
vides evidence that in  Drosophila melanogaster a signal-
ing network controlled by the LKB1 tumor suppressor 
regulates traffi cking of an Sln/dMCT1 monocarboxylate 
transporter to the plasma membrane. This enables cells 
to import additional energy sources such as lactate and 
butyrate, enhancing the repertoire of fuels they can use to 
power vital activities.
 Correspondence to Beatrice M. Filippi: b.fi lippi@dundee.ac.uk; or Dario R. 
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These enzymes include isoforms of PAR1/MARK as well as 
SAD/BRSK and, unlike AMPK, are not stimulated by energy 
stress but have been implicated in controlling cell polarity ( Alessi 
et al., 2006 ). 
 A paper published in this issue of the  Journal of Cell Biol-
ogy describes a new role for LKB1 in  Drosophila melanogaster 
( Jang et al., 2008 ; see p. 11 ). The data that emerged from a for-
ward genetic screen suggest that the LKB1 signaling pathway 
controls the traffi cking of a  Drosophila homologue of the mono-
carboxylate transporter-1 (MCT1) to the apical membrane of 
polarized wing cells. The MCT1 transporter was termed 
Silnoon (Sln), meaning narrow eyes in Korean, because of the 
phenotype that identifi ed it in the screen. As there are many 
published studies on mammalian MCT1, dMCT1 is an intuitive 
alternative name for the  Drosophila MCT1 transporter and 
we thus refer to it as Sln/dMCT1. Mammalian MCT1 and Sln/
dMCT1 are predicted to function as integral membrane proteins 
containing 12 transmembrane-spanning segments with N- and 
C-terminal cytoplasmic domains. In  Drosophila , there are 18 
characterized MCT family members and 14 in humans. Most 
work has been done on mammalian forms of these enzymes. 
MCT1 – 4 function as symport cotransporters of protons and 
monocarboxylate such as lactate, butyrate, and pyruvate (for re-
view see  Enerson and Drewes, 2003 ;  Pierre and Pellerin, 2005 ; 
for review see  Morris and Felmlee, 2008 ). Other MCT family 
members are likely to carry other substrates, for example, MCT8 
transports thyroid hormones and MCT6 transports prostaglan-
din F2  as well as several pharmaceutical drugs (for review see 
 Morris and Felmlee, 2008 ). 
 Jang et al. (2008) identifi ed Sln/dMCT1 as a gene that when 
overexpressed together with wild-type LKB1, but not kinase-
inactive LKB1, induced  Drosophila to develop narrow eyes and 
upwardly curved small wings. Moreover, overexpression of LKB1 
and Sln/dMCT1 in  Drosophila wing discs enhanced uptake of 
radiolabeled butyrate and lactate. This enhanced uptake was 
inhibited by mutation of an essential conserved MCT catalytic 
residue. The authors provide evidence that the narrow eyes and 
curved small wing phenotypes result from apoptosis triggered 
by the increased uptake of monocarboxylates. How enhanced 
uptake of monocarboxylates induces apoptosis is not established, 
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which has been proposed to trigger relocalization of GLUT4-
containing vesicles to the plasma membrane ( Fig. 1 ). 
 Although the phenotypic data presented in  Jang et al. (2008) 
are convincing, there are some noteworthy limitations. To ob-
serve apical localization of Sln/dMCT1,  Jang et al. (2008) over-
expressed wild-type LKB1. The assumption was that under these 
conditions, LKB1 would phosphorylate its physiological sub-
strates. LKB1 needs to interact with its STRAD and MO25 reg-
ulators to be activated as well as to be localized in the cytoplasm 
rather than the nucleus ( Alessi et al., 2006 ). Overexpression of 
LKB1 in  Drosophila , without STRAD and MO25, might be 
expected to result in the accumulation of inactive LKB1 in the 
nucleus that cannot activate downstream pathways. Moreover, 
in mammalian cells, LKB1 is constitutively active and there is 
suffi cient endogenous LKB1 to fully activate AMPK and AMPK-
related kinases without the need to resort to LKB1 overexpres-
sion ( Alessi et al., 2006 ). An over reliance on overexpressing 
LKB1 may have affected interpretations of previous analysis of 
LKB1 signaling in  Drosophila . For example, earlier research 
concluded that the  Drosophila Par1/MARK kinases phosphory-
lated and controlled LKB1 ( Martin and St Johnston, 2003 ), 
when it is now clear that LKB1 regulates Par1/MARK kinases 
( Lizcano et al., 2004 ). Moreover, the authors of the Sln/dMCT1 
study have reported that LKB1 regulated mitotic cell division 
and epithelial polarization via AMPK, directly phosphorylating 
the nonmuscle myosin regulatory light chain (MRLC;  Lee et al., 
2007 ). A recent study found that in LKB1-defi cient pancreatic 
cells that lack AMPK activity phosphorylation of MRLC was 
enhanced rather than ablated ( Hezel et al., 2008 ). Moreover, 
others have been unable to demonstrate that highly purifi ed 
AMPK phosphorylates MRLC in vitro under conditions where 
it phosphorylates other established substrates. Further work is 
therefore required to understand how LKB1 regulates MRLC. 
It is also possible that there are differences between mammalian 
but the authors postulate that inhibition of histone deacetylase 
by butyrate and/or activation of p53-dependent apoptosis might 
be involved based on previous work (for review see  Gupta et al., 
2006 ). Potentially, the apoptotic phenotypes observed in this 
study could have resulted from high levels of nonphysiological 
import of monocarboxylates caused by the overexpression of 
Sln/dMCT1 and LKB1. Another  Drosophila MCT termed OUT, 
most related to human MCT13, was also recently shown to control 
p53-triggered apoptosis of primordial germ cells during develop-
ment ( Yamada et al., 2008 ). 
 A key question concerns how overexpression of LKB1 
stimulates the monocarboxylate Sln/dMCT1-dependent uptake. 
Previous experiments on the regulation of MCT family trans-
porters have focused on the control of these enzymes at the level 
of transcription and translation (for review see  Morris and Felmlee, 
2008 ). However, in the fl y wing disc, LKB1 does not appear to 
infl uence Sln/dMCT1 expression, but instead induces a striking 
relocalization of Sln/dMCT1 from the basolateral to the apical 
membrane. Indeed, when kinase-defi cient LKB1 was expressed 
or LKB1 expression was reduced by siRNA, Sln/dMCT1 was 
predominantly localized on the basolateral wing disc membrane. 
Incubation of wing discs overexpressing wild-type LKB1 and 
Sln/dMCT1 with butyrate (but not lactate) induced massive apop-
tosis, which was not observed in the absence of LKB1, i.e., when 
Sln/dMCT1 was at the basolateral membrane. 
 In future work it will be crucial to establish whether LKB1 
also controls MCTs in mammalian cells. It will also be impor-
tant to determine whether the effects of LKB1 on Sln/dMCT1 
traffi cking are mediated via an AMPK family member and, if 
so, identify which one is involved. An attractive model would 
be if an AMPK directly phosphorylated Sln/dMCT1/MCT, 
thus promoting its traffi cking to the apical membrane. However, 
analysis of the Sln/dMCT1 sequence for putative AMPK family 
phosphorylation site motifs using Scansite database (http://
scansite.mit.edu/) reveals only a weak  “ low stringency ” site 
that is not conserved in human or mouse MCT1. No putative 
AMPK phosphorylation site motifs were revealed in analysis of 
mammalian MCT1 sequences. Membrane localization of mam-
malian MCT1 and MCT2 is also reported to be stabilized 
through their interaction with glycoproteins (CD147 for MCT1 
and Gp70 for MCT2; for reviews see  Enerson and Drewes, 
2003 ;  Morris and Felmlee, 2008 ). It will also be important to 
investigate whether the LKB1 – AMPK pathway can infl uence the 
interaction of Sln/dMCT1/MCT with membrane-anchoring glyco-
proteins. Scansite analysis does not reveal obvious AMPK se-
quence consensus motifs in either CD147 or Gp70. Collectively, 
these observations suggest that the effects of LKB1 on Sln/
dMCT1 trafficking, if indeed mediated via activation of an 
AMPK, would involve an intermediate substrate. 
 The proposed pathway by which LKB1 regulates the traf-
fi cking of MCTs has similarities to the mechanism by which 
exercise stimulates translocation of the glucose transporter GLUT4 
from intracellular vesicles to the plasma membrane ( Fig. 1 ). 
In contracting muscle, depletion of ATP leads to activation of 
AMPK, which phosphorylates and inhibits the Rab-GTPase –
 activating proteins termed AS160 and TBC1D1 ( Sakamoto 
and Holman, 2008 ). This stimulates loading of GTP to Rab8A, 
 Figure 1.  Comparison of potential mechanisms by which LKB1 controls 
monocarboxylate and GLUT4 glucose transporters. In contracting muscle, 
depletion of ATP leads to activation of AMPK, which phosphorylates and 
inhibits the Rab-GTPase – activating proteins termed AS160 and TBC1D1. 
This leads to an increase in the levels of active (GTP-bound) Rab8A that 
promotes relocalization of GLUT4 to the plasma membrane. AMPK or an 
AMPK-related kinase could phosphorylate an intermediate substrate to in-
duce the translocation of MCT1/Sln to the plasma membrane. 
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and insect signaling networks regulating LKB1 and MRLC. 
AMPK has also been shown to phosphorylate and regulate 
 myosin light chain kinase, which represents another mechanism 
by which the LKB1 pathway might affect MRLC phosphorylation 
( Horman et al., 2008 ). The authors of  Jang et al. (2008) have 
also reported that LKB1 controls apoptosis by activating the JNK 
pathway ( Lee et al., 2006 ), although this has not yet been con-
fi rmed in any subsequent study. 
 Monocarboxylates such as lactate have long been consid-
ered as waste products to be disposed of before harmful levels 
accumulate. However, these molecules also comprise vital en-
ergy substrates for brain and muscle under conditions where 
glucose or other nutrients are scarce ( Pellerin, 2003 ;  Pierre and 
Pellerin, 2005 ). Butyrate is also produced by colonic bacterial 
fermentation of dietary carbohydrates and serves as the major 
respiratory fuel for colonic epithelial cells ( Cuff et al., 2005 ). 
How energy stress or other signals prompt cells to use mono-
carboxylates as a fuel source is unknown. Given the results 
presented in  Jang et al. (2008) , it is possible that relocalization 
of MCTs to the membrane, at least after energy stress, is trig-
gered by LKB1-mediated activation of AMPK. Similarly, al-
teration of cellular structures during polarization must consume 
considerable energy. The ability of cells to import mono-
carboxylates may aide in providing additional injection of fuel 
to power polarization. 
 The  Jang et al. (2008) fi ndings suggest that loss of LKB1 
would hinder the ability of cancer cells to use monocarboxylates 
as an energy source. At fi rst glance, limiting the substrates that a 
cancer cell could exploit as a source of fuel seems detrimental. 
However, in colonic epithelia during transition to malignancy, a 
decline in MCT1 expression and a switch from using butyrate to 
glucose as an energy source has been observed ( Lambert et al., 
2002 ). Furthermore, a hallmark of loss of LKB1 expression in 
human and mice is a dramatic failure of colonic intestinal cells to 
polarize, resulting in polyp growth ( Katajisto et al., 2008 ). Thus, 
disruption of monocarboxylate import pathways may promote 
tumor formation by interfering with energy supplies required to 
power polarization. Loss of monocarboxylate transport in cancer 
might also promote survival through decreased monocarboxylate-
dependent apoptosis. It would indeed be interesting to explore in 
more depth the importance of monocarboxylate transport in con-
trolling polarization and whether inability of LKB1-defi cient 
cancer cells to import monocarboxylates represents a weakness 
in their armory that could be exploited therapeutically. 
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